236 related articles for article (PubMed ID: 36017367)
1. Multiparametric analysis of host and parasite elements in new world tegumentary leishmaniasis.
de Carvalho BC; Vital T; Osiro J; Gomes CM; Noronha E; Dallago B; Rosa AC; Carvalho JL; Hagström L; Hecht M; Nitz N
Front Cell Infect Microbiol; 2022; 12():956112. PubMed ID: 36017367
[TBL] [Abstract][Full Text] [Related]
2. First Molecular Report of
Salvioni Recalde OD; Pereira Brunelli J; Rolon MS; Rojas de Arias A; Aldama O; Gómez CV
Am J Trop Med Hyg; 2019 Oct; 101(4):780-788. PubMed ID: 31407656
[TBL] [Abstract][Full Text] [Related]
3. Clinical and histopathologic features of canine tegumentary leishmaniasis and the molecular characterization of Leishmania braziliensis in dogs.
Lago J; Silva JA; Borja L; Fraga DBM; Schriefer A; Arruda S; Lago E; Carvalho EM; Bacellar O
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007532. PubMed ID: 31310601
[TBL] [Abstract][Full Text] [Related]
4. Co-expression analysis of lncRNA and mRNA suggests a role for ncRNA-mediated regulation of host-parasite interactions in primary skin lesions of patients with American tegumentary leishmaniasis.
Almeida MC; Felix JS; Lopes MFDS; de Athayde FRF; Troiano JA; Scaramele NF; Furlan AO; Lopes FL
Acta Trop; 2023 Sep; 245():106966. PubMed ID: 37302689
[TBL] [Abstract][Full Text] [Related]
5. Further Evidence of an Association between the Presence of Leishmania RNA Virus 1 and the Mucosal Manifestations in Tegumentary Leishmaniasis Patients.
Cantanhêde LM; da Silva Júnior CF; Ito MM; Felipin KP; Nicolete R; Salcedo JM; Porrozzi R; Cupolillo E; Ferreira Rde G
PLoS Negl Trop Dis; 2015; 9(9):e0004079. PubMed ID: 26372217
[TBL] [Abstract][Full Text] [Related]
6. Tegumentary leishmaniasis by Leishmania braziliensis complex in Cochabamba, Bolivia including the presence of L. braziliensis outlier: Tegumentary leishmaniasis in Cochabamba, Bolivia: Tegumentary leishmaniasis in Cochabamba, Bolivia.
Torrico MC; Fernández-Arévalo A; Ballart C; Solano M; Rojas E; Ariza E; Tebar S; Lozano D; Abras A; Gascón J; Picado A; Muñoz C; Torrico F; Gállego M
Transbound Emerg Dis; 2022 Jul; 69(4):2242-2255. PubMed ID: 34232559
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomics analysis highlights potential ways in human pathogenesis in Leishmania braziliensis infected with the viral endosymbiont LRV1.
Felipin KP; Paloschi MV; Silva MDS; Ikenohuchi YJ; Santana HM; Setúbal SDS; Rego CMA; Lopes JA; Boeno CN; Serrath SN; De Medeiros EHRT; Pimentel IF; Oliveira AER; Cupolillo E; Cantanhêde LM; Ferreira RGM; Zuliani JP
PLoS Negl Trop Dis; 2024 May; 18(5):e0012126. PubMed ID: 38743668
[TBL] [Abstract][Full Text] [Related]
8. Distinct genetic profiles of Leishmania (Viannia) braziliensis associate with clinical variations in cutaneous-leishmaniasis patients from an endemic area in Brazil.
Quaresma PF; de Brito CFA; Rugani JMN; Freire JM; Baptista RP; Moreno EC; Gontijo RC; Rego FD; Diniz JE; Melo MN; Gontijo CMF
Parasitology; 2018 Aug; 145(9):1161-1169. PubMed ID: 29526166
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry in the Characterization of
Torrico MC; Fernández-Arévalo A; Ballart C; Solano M; Rojas E; Abras A; Gonzales F; Arnau A; Tebar S; Llovet T; Lozano D; Ariza-Vioque E; Gascón J; Picado A; Torrico F; Muñoz C; Gállego M
Microbiol Spectr; 2023 Feb; 11(1):e0347722. PubMed ID: 36633426
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of proteins secreted by Leishmania (Viannia) braziliensis strains associated to distinct clinical manifestations of American Tegumentary Leishmaniasis.
Rodríguez-Vega A; Losada-Barragán M; Berbert LR; Mesquita-Rodrigues C; Bombaça ACS; Menna-Barreto R; Aquino P; Carvalho PC; Padrón G; de Jesus JB; Cuervo P
J Proteomics; 2021 Feb; 232():104077. PubMed ID: 33309930
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylases inhibitors as new potential drugs against Leishmania braziliensis, the main causative agent of new world tegumentary leishmaniasis.
Ângelo de Souza L; Silva E Bastos M; de Melo Agripino J; Souza Onofre T; Apaza Calla LF; Heimburg T; Ghazy E; Bayer T; Ferraz da Silva VH; Dutra Ribeiro P; Licursi de Oliveira L; Costa Bressan G; de Almeida Lamêgo MR; Silva-Júnior A; de Souza Vasconcellos R; Suarez-Fontes AM; Almeida-Silva J; Vannier-Santos MA; Pierce R; Sippl W; Lopes Rangel Fietto J
Biochem Pharmacol; 2020 Oct; 180():114191. PubMed ID: 32777278
[TBL] [Abstract][Full Text] [Related]
12. Presence of parasite DNA in clinically unaffected nasal mucosa during cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.
Canário A; Queiroz M; Cunha G; Cavalcante T; Riesz V; Sharma R; de Noronha A; Correia T; Barral-Netto M; Barral A; Khouri R; Boaventura V
Clin Microbiol Infect; 2019 Apr; 25(4):515.e5-515.e7. PubMed ID: 30616010
[TBL] [Abstract][Full Text] [Related]
13. Identification of Leishmania species by high-resolution DNA dissociation in cases of American cutaneous leishmaniasis.
Veasey JV; Zampieri RA; Lellis RF; Freitas THP; Winter LMF
An Bras Dermatol; 2020; 95(4):459-468. PubMed ID: 32518010
[TBL] [Abstract][Full Text] [Related]
14. [Role of three ELISA tests using promastigote homogenates of Leishmania braziliensis, L. amazonensis and L. guyanensis in the diagnosis of tegumentary leishmaniasis].
Gil JF; Hoyos CL; Cimino RO; Krolewiecki AJ; López Quiroga I; Cajal SP; Juárez M; García Bustos MF; Mora MC; Marco JD; Nasser JR
Medicina (B Aires); 2011; 71(5):420-8. PubMed ID: 22057166
[TBL] [Abstract][Full Text] [Related]
15. Clinical-therapeutic follow-up of patients with American cutaneous leishmaniasis caused by different Leishmania spp. in Brazil.
Morais RCS; Melo MGN; Goes TC; Pessoa E Silva R; de Morais RF; Guerra JAO; de Brito MEF; Brandão-Filho SP; de Paiva Cavalcanti M
Exp Parasitol; 2022 Sep; 240():108338. PubMed ID: 35917898
[TBL] [Abstract][Full Text] [Related]
16. Development of real-time PCR assays for evaluation of immune response and parasite load in golden hamster (Mesocricetus auratus) infected by Leishmania (Viannia) braziliensis.
Ribeiro-Romão RP; Saavedra AF; Da-Cruz AM; Pinto EF; Moreira OC
Parasit Vectors; 2016 Jun; 9(1):361. PubMed ID: 27350537
[TBL] [Abstract][Full Text] [Related]
17. Dual Role of Insulin-Like Growth Factor (IGF)-I in American Tegumentary Leishmaniasis.
de O Mendes-Aguiar C; Lopes-Siqueira C; Pettito-Assis F; Pereira-Oliveira M; de Oliveira-Neto MP; Pirmez C; Da-Cruz AM; Goto H
J Immunol Res; 2021; 2021():6657785. PubMed ID: 33860062
[TBL] [Abstract][Full Text] [Related]
18. DNA sequencing confirms the involvement of Leishmania (L.) amazonensis in American tegumentary leishmaniasis in the state of São Paulo, Brazil.
Medeiros AR; Silva WA; Roselino AM
Clinics (Sao Paulo); 2008 Aug; 63(4):451-6. PubMed ID: 18719754
[TBL] [Abstract][Full Text] [Related]
19. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.
Gomes RS; Silva MVT; Dos Santos JC; de Lima Silva LL; Batista AC; Machado JR; Teixeira MM; Dorta ML; de Oliveira MAP; Dinarello CA; Joosten LAB; Ribeiro-Dias F
Parasit Vectors; 2017 Jul; 10(1):336. PubMed ID: 28709468
[TBL] [Abstract][Full Text] [Related]
20. Identification and Biological Characterization of Leishmania (Viannia) guyanensis Isolated from a Patient with Tegumentary Leishmaniasis in Goiás, a Nonendemic Area for This Species in Brazil.
Pires Ada S; Borges AF; Cappellazzo Coelho A; Dorta ML; Lino Junior Rde S; Pereira LI; Pinto SA; Pelli de Oliveira MA; de Matos GG; Abrahamsohn IA; Uliana SR; Lima GM; Ribeiro-Dias F
Biomed Res Int; 2015; 2015():350764. PubMed ID: 26583102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
